MarketPeel
Insider Trading Intelligence
Pricing
…
JH

Jonathan Hepple

APRE
DIRECTOR · APREA THERAPEUTICS, INC. · CIK 0001789045
FILING MIX · LIFETIME100%/0%
BUYS
1
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
5,600
AVG SELL PX
—
TRADE KIND
SHOWING 1 / 1
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Jonathan Hepple. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
Not enough transaction history to chart holdings.
Trading cadence · quarterly flow
BUY ● SELL ●
2020
FLOW · 1 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
APRE
APREA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,600——5,600Jun 30, 2020Jul 1, 2020 ↗
Other insiders · APRE
Loading peer insiders…
About this filer
CIK 0001789045
ROLE
Director
PRIMARY
APRE
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001789045DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback